73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according
Study: Fat cells play key role in dangerous transformation of melanoma

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr
New imaging technology for diagnosing and treating bowel cancer patients

New imaging technology for diagnosing and treating bowel cancer patients

byUniversity of GlasgowRepresentative transverse PET images from each mouse model and tracer. Credit:Clinical Cancer Research(2024). DOI: 10.1158/1078-0432.CCR-23-1063Biopsies are cu

New imaging technology for diagnosing and treating bowel cancer patients

byUniversity of GlasgowRepresentative transverse PET images from each mouse model and tracer. Credit:Clinical Cancer Research(2024). DOI: 10.1158/1078-0432.CCR-23-1063Biopsies are cu
Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

November 2023Thomas R. CollinsMolecules that link cancer driver genes and promoters of cell death genes produce potent killing of diffuse large B-cell lymphoma (DLBCL) cells, according to findings pub

Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

November 2023Thomas R. CollinsMolecules that link cancer driver genes and promoters of cell death genes produce potent killing of diffuse large B-cell lymphoma (DLBCL) cells, according to findings pub
Protein linked to aggressive skin cancer

Protein linked to aggressive skin cancer

by Lund UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Almost 300,000 people worldwide develop malignan

Protein linked to aggressive skin cancer

by Lund UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Almost 300,000 people worldwide develop malignan
Researchers develop new drug that fights cancer with less renal toxicity

Researchers develop new drug that fights cancer with less renal toxicity

by National University of SingaporeA novel anti-cancer drug developed by Assoc Prof Giorgia Pastorin, Assoc Prof Ang Wee Han and Dr Maria Babak (left to right) effectively shrinks tumours until t

Researchers develop new drug that fights cancer with less renal toxicity

by National University of SingaporeA novel anti-cancer drug developed by Assoc Prof Giorgia Pastorin, Assoc Prof Ang Wee Han and Dr Maria Babak (left to right) effectively shrinks tumours until t
Drug combo heralds major shift in chronic lymphocytic leukemia treatment

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali
Tracking the epigenetic evolution of a cancer, cell by cell

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables
Screening has had 'little impact' on falling breast cancer deaths in the Netherlands

Screening has had 'little impact' on falling breast cancer deaths in the Netherlands

by British Medical JournalMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast screening in the Netherlands seems to have had a marginal effect

Screening has had 'little impact' on falling breast cancer deaths in the Netherlands

by British Medical JournalMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast screening in the Netherlands seems to have had a marginal effect
Japan Nobel winner vows to continue research to 'save more patients than ever'

Japan Nobel winner vows to continue research to 'save more patients than ever'

Credit: CC0 Public DomainThe Japanese scientist who Mondaywon the Nobel Prizefor medicine vowed to continue his cancer treatment work to help as many sufferers as possible, saying treating

Japan Nobel winner vows to continue research to 'save more patients than ever'

Credit: CC0 Public DomainThe Japanese scientist who Mondaywon the Nobel Prizefor medicine vowed to continue his cancer treatment work to help as many sufferers as possible, saying treating
Study finds patient messages help predict medication adherence

Study finds patient messages help predict medication adherence

by Paul Govern,Vanderbilt UniversityCredit: CC0 Public DomainAround two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, wi

Study finds patient messages help predict medication adherence

by Paul Govern,Vanderbilt UniversityCredit: CC0 Public DomainAround two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, wi
Workaround erases side effects of promising cell-based cancer therapy

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret